Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 8/20 | 0.43 |
| ▸ | FNTB | P49356 | 8/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284629 | 0.97 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL4284627 | 0.97 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL30575172 | 0.95 | LMNA (0.48) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL29630436 | 0.93 | MME (0.45) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL30642092 | 0.92 | FNTA (0.48) | FNTAFNTBPGGT1B | |
| SCHEMBL31438607 | 0.90 | PDCD1LG2 (0.42) | LMNAFNTAFNTBPGGT1BTGFBR1 | |
| SCHEMBL17867157 | 0.90 | FOLH1 (0.52) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL17867160 | 0.90 | FOLH1 (0.52) | LMNAFNTAFNTBPGGT1BMME | |
| SCHEMBL29350482 | 0.90 | LMNA (0.43) | LMNAFNTAFNTBPGGT1BCA2 | |
| SCHEMBL30112746 | 0.90 | METAP2 (0.41) | LMNAFNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |